Tadic M, Cuspidi C, Marwick TH. Phenotyping the hypertensive heart. Eur Heart J. 2022;43(38):3794–810.

Article  PubMed  Google Scholar 

Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E. Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients. Eur Heart J Cardiovasc Imaging. 2017;18(9):945–60.

Article  PubMed  Google Scholar 

Williams B, Mancia G, Spiering W, AgabitiRosei E, Azizi M, Burnier M, Clement D, Coca A, De Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis K, Aboyans V, Desormais I. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Blood Press. 2018;27(6):314–40.

Article  PubMed  Google Scholar 

Mancusi C, Lembo M, Manzi MV, Basile C, Fucile I, Morisco C. From structural to functional hypertension mediated target organ damage—a long way to heart failure with preserved ejection fraction. J Clin Med. 2022;11(18):5377.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141(3):334–41.

Article  CAS  PubMed  Google Scholar 

Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. N Engl J Med. 1990;322(22):1561–6.

Article  CAS  PubMed  Google Scholar 

Vasan RS, Urbina EM, Jin L, Xanthakis V. Prognostic significance of echocardiographic measures of cardiac remodeling in the community. Curr Cardiol Reports. 2021. https://doi.org/10.1007/s11886-021-01512-4.

Article  Google Scholar 

Fitzpatrick JK, Ambrosy AP, Parikh RV, Tan TC, Bansal N, Go AS. Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease. Am Heart J. 2022;248:84–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Özbek BT, Modin D, Møgelvang R, Jørgensen PG, Jensen MT, Schnohr P, Gislason GH, Biering-Sørensen T. Echocardiographic predictors of long-term adverse cardiovascular outcomes in participants with and without diabetes mellitus: a follow-up analysis of the Copenhagen City Heart Study. Diabet Med. 2021. https://doi.org/10.1111/dme.14627.

Article  PubMed  Google Scholar 

Desai CS, Bartz TM, Gottdiener JS, Lloyd-Jones DM, Gardin JM. Usefulness of left ventricular mass and geometry for determining 10-year prediction of cardiovascular disease in adults aged >65 years (from the cardiovascular health study). Am J Cardiol. 2016;118(5):684–90.

Article  PubMed  PubMed Central  Google Scholar 

Douglas PS. The left atrium: a biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am College Cardiol. 2003;42(7):1206–7.

Article  Google Scholar 

Khan MA, Yang EY, Zhan Y, Judd RM, Chan W, Nabi F, Heitner JF, Kim RJ, Klem I, Nagueh SF, Shah DJ. Association of left atrial volume index and all-cause mortality in patients referred for routine cardiovascular magnetic resonance: a multicenter study. J Cardiovasc Magn Reson. 2019. https://doi.org/10.1186/s12968-018-0517-0.

Article  PubMed  PubMed Central  Google Scholar 

Gardin JM, Arnold AM, Polak J, Jackson S, Smith V, Gottdiener J. Usefulness of aortic root dimension in persons ≥65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study). Am J Cardiol. 2006;97(2):270–5.

Article  PubMed  Google Scholar 

Lai CL, Chien KL, Hsu HC, Su TC, Chen MF, Lee YT. Aortic root dimension as an independent predictor for all-cause death in adults < 65 years of age (from the chin-shan community cardiovascular cohort study). Echocardiography. 2010;27(5):487–95.

Article  PubMed  Google Scholar 

Kim HM, Hwang IC, Choi HM, Yoon YE, Cho GY. Prognostic implication of left ventricular hypertrophy regression after antihypertensive therapy in patients with hypertension. Front Cardiovasc Med. 2022. https://doi.org/10.3389/fcvm.2022.1082008.

Article  PubMed  PubMed Central  Google Scholar 

Martin TG, Juarros MA, Leinwand LA. Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential. Nat Rev Cardiol. 2023;20(5):347–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13(12):1377–90.

Article  CAS  PubMed  Google Scholar 

Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, Ferrario M, Mancia G. Blood pressure variability and organ damage in a general population: results from the PAMELA study. Hypertension. 2002;39(2):710–4.

Article  CAS  PubMed  Google Scholar 

Grassi G, Quarti-Trevano F, Dell’Oro R, Cuspidi C, Mancia G. The PAMELA research project: a 25-year long journey. Panminerva Med. 2021. https://doi.org/10.23736/S0031-0808.21.04396-2.

Article  PubMed  Google Scholar 

Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Cheng S, Aragam J, Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Relations of central hemodynamics and aortic stiffness with left ventricular structure and function: the framingham heart study. J Am Heart Assoc. 2015. https://doi.org/10.1161/JAHA.115.002693.

Article  PubMed  PubMed Central  Google Scholar 

Grassi G, Seravalle G, Mancia G. Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications. Eur J Clin Investigat. 2015;45(12):1367–75.

Article  Google Scholar 

du Toit WL, Schutte AE, Gafane-Matemane LF, Kruger R, Mels CMC. The renin-angiotensin-system and left ventricular mass in young adults: the African-PREDICT study. Blood Press. 2021;30(2):98–107.

Article  PubMed  Google Scholar 

Lillo R, Graziani F, Franceschi F, Iannaccone G, Massetti M, Olivotto I, Crea F, Liuzzo G. Inflammation across the spectrum of hypertrophic cardiac phenotypes. Heart Fail Rev. 2023;28(5):1065–75.

Article  PubMed  PubMed Central  Google Scholar 

Lin A, Pieszko K, Park C, Ignor K, Williams MC, Slomka P, Dey D. Artificial intelligence in cardiovascular imaging: enhancing image analysis and risk stratification. BJR Open. 2023. https://doi.org/10.1259/bjro.20220021.

Article  PubMed  PubMed Central  Google Scholar 

Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35(2):580–6.

Article  CAS  PubMed  Google Scholar 

Rosei EA, Muiesan ML, Salvetti M, Paini A, Rosei CA, Aggiusti C, Bertacchini F, Castellano M, Giacchè M. The vobarno study. Panminerva Med. 2021. https://doi.org/10.23736/S0031-0808.21.04433-5.

Article  Google Scholar 

Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, Valagussa F, Bombelli M, Giannattasio C, Zanchetti A, Mancia G. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104(12):1385–92.

Article  CAS  PubMed  Google Scholar 

Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Hypertension. 2002;39(3):744–9.

Article  CAS  PubMed  Google Scholar 

Cuspidi C, Facchetti R, Bombelli M, Tadic M, Sala C, Grassi G, Mancia G. High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population. Hypertension. 2019;73(3):612–9.

Article  CAS  PubMed  Google Scholar 

Cuspidi C, Facchetti R, Bombelli M, Sala C, Negri F, Grassi G, Mancia G. Nighttime blood pressure and new-onset left ventricular hypertrophy: findings from the Pamela population. Hypertension. 2013;62(1):78–84.

Article  CAS  PubMed  Google Scholar 

Cuspidi C, Facchetti R, Quarti-Trevano F, Sala C, Tadic M, Grassi G, Mancia G. Incident left ventricular hypertrophy in masked hypertension. Hypertension. 2019;74(1):56–62.

Article  CAS  PubMed  Google Scholar 

Mancia G, Facchetti R, Vanoli J, Dell’Oro R, Seravalle G, Grassi G. White-coat hypertension without organ damage: impact on long-term mortality, new hypertension, and new organ damage. Hypertension. 2022;79(5):1057–66.

Article  CAS  PubMed  Google Scholar 

Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis. Am J Hypertens. 2015;28(12):1392–402.

Article  PubMed  Google Scholar 

Mancia G, Facchetti R, Bombelli M, Cuspidi C, Grassi G. White-coat hypertension: pathophysiological and clinical aspects: excellence award for hypertension research 2020. Hypertension. 2021;78(6):1677–88.

Article  CAS  PubMed  Google Scholar 

Cuspidi C, Quarti F, Dell’Oro R, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, Mancia G. Long-term changes in left ventricular mass echocardiographic findings from a general population. J Hypertens. 2017;35(11):2303–9.

Article  CAS